Premier, Hospitals Laud HRSA’s Move to Not Appeal Ruling that Struck Down Drug Purchasing Restrictions Policy
Published 6/12/26
340B Report highlights the decision by the Health Resources and Services Administration (HRSA) not to appeal a federal court ruling that vacated a 2013 policy restricting how certain 340B hospitals purchase initial drug inventory. The article features insights from Bruce Radcliff, president of supply chain services at Premier, who says the decision provides hospitals with greater flexibility to manage pharmacy purchasing while reducing unnecessary complexity and costs. Premier will continue monitoring any future regulatory action related to the issue and advocating for policies that support provider efficiency and patient access to care.
